Ozempic and Mounjaro reduce stroke and heart attack risk in type 2 diabetes patients

timesofindia.indiatimes.com

Ozempic and Mounjaro significantly reduce stroke and heart attack risk in type 2 diabetes patients. The study found these medications offer cardiovascular protection beyond weight loss and blood sugar control, with benefits appearing early. This research used real-world data, suggesting these drugs could be crucial in preventing heart disease, a major health threat.


With a significance score of 4.2, this news ranks in the top 4.1% of today's 31104 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: